Unclaimed Scholar Profile
Are you Anusha Nana? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-3646-0514-0531 orcid.org/0000-0003-0564-4043
Anusha Nana
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand (ZA), specializing in Agricultural, Environmental & Life Sciences. [Discipline: Agricultural, Environmental & Life Sciences] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#SARS-CoV-2 and COVID-19 Research#COVID-19 Clinical Research Studies#Vaccine Coverage and Hesitancy#HIV Research and Treatment
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 5,839 | 2,803 |
| h-index | 7 | 5 |
| i10-index | 6 | 4 |
Annual Citation Growth
Verified Citations / Year0
2020280
2021+40%392
2022+29%505
2023+33%673
2024-8%617
2025-46%336
2026Scholarship Distribution & Proportions8 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (4,788) • 18% Global Research Impact (1,051)
8 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (8)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
DOI: 10.1016/s0140-6736(20)32661-1 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
Published in JAMA Network Open•2023
DOI: 10.1001/jamanetworkopen.2022.51974 Verified Peer-Reviewed
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Published in PLOS Global Public Health•2024
DOI: 10.1371/journal.pgph.0002703 Verified Peer-Reviewed
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study
Published in EClinicalMedicine•2025
DOI: 10.1016/j.eclinm.2024.103054 Verified Peer-Reviewed
Showing 1 – 5 of 8 publications
1 / 2